Questo sito usa cookie per fornirti un'esperienza migliore. Proseguendo la navigazione accetti l'utilizzo dei cookie da parte nostra OK Approfondisci
LOD data

VOLUNTARY CONTRIBUTION 2025-CEPI-COALITION FOR EPIDEMIC PREPAREDNESS INNOVATION

Developing countries, unspecified

Status

Closed

Aid type

Core support to NGOs, other private bodies, PPPs and research institutes

Developing countries, unspecified


Location

-

€ 4,000,000
Committed
€ 4,000,000
Used

Description

Voluntary contribution to CEPI for its mission to accelerate the development of vaccines against emerging infectious diseases and enable equitable access to these vaccines. This contribution will support CEPI's Strategic Plan 2022-2026 identifies six main goals: Developing vaccines against known threats (Chikungunya, Lassa Fever, MERS, Nipah); reducing the timeline for new vaccine development to 100 days ("100-day moonshot"); assisting low- and middle-income countries in developing the infrastructure and expertise needed for epidemiological studies; establishing a network of laboratories for rapid vaccine development; and developing a universal vaccine against all coronaviruses and a "bank" of vaccine prototypes for all of the top 25 virus families. The contribution is consistent with SDG 3, particularly target 3.3, 3.8 3.b and 3.d, SDG 17, particularly target 17.16 and 17.17. read more close
Year Committed Used
2025 € 4,000,000 € 4,000,000

Agency

Type Name Channel code
Government AICS - Italian Agency for Cooperation and Development 11000

Channel reported

Type Name Channel code
organisation_type. CEPI - COALITION FOR EPIDEMIC PREPAREDNESS INNOVATIONS ALT 31006

Project data

  • IATI IdentifierXM-DAC-6-4-012350-01-4
  • AID012350/01/4
  • CRS Activity identifier2025040025
  • Planned start 2025/04/08
  • Planned End 2025/12/31
  • Actual start 2025/09/01
  • Actual end 2025/12/02
  • Bi/Multilateral Bilateral, core contributions to NGOs and other private bodies / PPPs
  • Status Closed
  • Tied status Untied

Sectors

  • 12250 - Infectious disease control 100.0%

Policy markers

  • Gender Equality not targeted
  • Disaster Risk Reduction(DRR) not targeted
  • Disability not targeted
  • Nutrition not targeted
  • Aid to Environment not targeted
  • Participatory Development/Good Governance not targeted
  • Trade Development not targeted
  • Aid Targeting the Objectives of the Convention on Biological Diversity not targeted
  • Aid Targeting the Objectives of the Framework Convention on Climate Change - Mitigation not targeted
  • Aid Targeting the Objectives of the Framework Convention on Climate Change - Adaptation not targeted
  • Aid Targeting the Objectives of the Convention to Combat Desertification not targeted
  • Reproductive, Maternal, Newborn and Child Health (RMNCH) not targeted

SDGs

  • 17.8 - Fully operationalize the technology bank and science, technology and innovation capacity-building mechanism for least developed countries by 2017 and enhance the use of enabling technology, in particular information and communications technology
  • 3.3 - By 2030, end the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases and combat hepatitis, water-borne diseases and other communicable diseases
  • 3.b - Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all
-
-
-